A phase I-II study of paclitaxel, ifosfamide, and vinorelbine with filgrastim (rhG-CSF) support in advanced non-small-cell lung cancer.

A phase I-II study of paclitaxel, ifosfamide, and vinorelbine with filgrastim (rhG-CSF) support in advanced non-small-cell lung cancer. Ann Oncol. 1998 Jun; 9(6):677-80.

View in: PubMed

subject areas

Adult
Aged
Aged, 80 and over
Antineoplastic Agents, Alkylating
Antineoplastic Agents, Phytogenic
Antineoplastic Combined Chemotherapy Protocols
Carcinoma, Non-Small-Cell Lung
Dose-Response Relationship, Drug
Female
Filgrastim
Follow-Up Studies
Granulocyte Colony-Stimulating Factor
Humans
Ifosfamide
Lung Neoplasms
Male
Middle Aged
Neoplasm Staging
Paclitaxel
Recombinant Proteins
Survival Rate
Vinblastine

authors with profiles

Ann Marie Mauer
Harvey M. Golomb
Philip Charles Hoffman